Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 104,061 | 107,199 | 108,637 | 97,231 | 97,529 |
| Gross Profit | 104,061 | 107,199 | 108,637 | 97,231 | 97,529 |
| Operating Expenses | 43,964 | 38,836 | 40,164 | 41,576 | 39,683 |
| Operating Income | 60,097 | 68,363 | 68,473 | 55,655 | 57,846 |
| Interest Expense | 1,527 | 1,526 | 1,524 | 2,207 | 2,341 |
| Other Income | 7,291 | 5,428 | 2,958 | 337 | 960 |
| Pre-tax Income | 65,861 | 72,265 | 69,907 | 53,785 | 56,465 |
| Income Tax | 20,147 | 23,398 | 19,590 | 16,705 | 17,664 |
| Net Income Continuous | 45,714 | 48,867 | 50,317 | 37,080 | 38,801 |
| Net Income | $45,714 | $48,867 | $50,317 | $37,080 | $38,801 |
| EPS Basic Total Ops | 0.30 | 0.31 | 0.33 | 0.24 | 0.25 |
| EPS Basic Continuous Ops | 0.30 | 0.32 | 0.33 | 0.24 | 0.25 |
| EPS Diluted Total Ops | 0.25 | 0.26 | 0.28 | 0.21 | 0.21 |
| EPS Diluted Continuous Ops | 0.24 | 0.26 | 0.27 | 0.20 | 0.20 |
| EBITDA(a) | $60,383 | $68,703 | $68,836 | $56,015 | $58,201 |